Inactivated HMPV A Antigen

  • Check with publisher
  • Published date: February 25, 2019
    • Shirley, New York, United States

Human metapneumovirus (HMPV) is a member of the Paramyxoviridae virus family. It is a negative-sense single-stranded RNA and is closely related to the avian metapneumovirus (AMPV) subgroup C. Infection in the upper respiratory tract is associated with mild illness, while lower respiratory tract infection can cause fever, cough, pneumonia, bronchiolitis and wheezing. Severe lower respiratory tract infection is most common in the very young, the very old and the immunosuppressed. The peak age of hospitalization for infants with HMPV occurs between 6–12 months of age, slightly older than the peak of RSV, which is around 2–3 months. The clinical features and severity of HMPV are similar to those of RSV. HMPV is also an important cause of disease in older adults. https://www.creative-biolabs.com/vaccine/inactivated-hmpv-a-antigen-306.htm

Result 0 votes
Jerry Carter
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Data Integrity: FDA/EU Requirements and Implementation

    Data Integrity: FDA/EU Requirements and Implementation

    Life Sciences (Copenhagen) April 28, 2020 Check with publisher

    This 2-day course explains the background to the data integrity regulations and sets out the expectations of pharmaceutical regulators. All the current data integrity guidances emphasise a risk-based approach to compliance, and the course explains ho...

  • 5th Annual ComplianceOnline Medical Device Summit 2020

    5th Annual ComplianceOnline Medical Device Summit 2020

    Life Sciences Massachusetts (Boston) February 12, 2020 Check with publisher

    ComplianceOnline Medical Device Summit 2020 brings together Speakers and executives from FDA/CDRH, Ex-FDA Officials and Renowned R&D experts and technology innovators to share information regarding opportunities, obstacles, best practices and cha...

  • 4th Annual Genome Editing USA Congress

    4th Annual Genome Editing USA Congress

    Life Sciences Boston (Massachusetts) December 23, 2019 Check with publisher

    350+ end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical & biotech companies. 3 outstanding programmes bringing together ...